{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T13:17:43Z","timestamp":1776431863174,"version":"3.51.2"},"reference-count":23,"publisher":"The Endocrine Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,11,1]]},"abstract":"<jats:p>Receptor activity-modifying proteins (RAMPs) 1, 2, and 3 are prototypic G protein-coupled receptor accessory proteins that can alter not only receptor trafficking but also receptor phenotype. Specific RAMP interaction with the calcitonin receptor (CTR) generates novel and distinct receptors for the peptide amylin; however, the role of RAMPs in receptor signaling is not understood. The current study demonstrates that RAMP interaction with the CTRa in COS-7 or HEK-293 cells leads to selective modulation of signaling pathways activated by the receptor complex. There was a 20- to 30-fold induction in amylin potency at CTR\/RAMP1 (AMY1) and CTR\/RAMP3 (AMY3) receptors, compared with CTR alone, for formation of the second-messenger cAMP that parallels an increase in amylin binding affinity. In contrast, only 2- to 5-fold induction of amylin potency was seen for mobilization of intracellular Ca++ or activation of ERK1\/2. In addition, in COS-7 cells, the increase in amylin potency for Ca++ mobilization was 2-fold greater for AMY3 receptors, compared with AMY1 receptors and this paralleled the relative capacity of overexpression of G\u03b1q proteins to augment induction of high affinity 125I-amylin binding. These data demonstrate that RAMP-complexed receptors have a different signaling profile to CTRs expressed in the absence of RAMPs, and this is likely due to direct effects of the RAMP on G protein-coupling efficiency.<\/jats:p>","DOI":"10.1210\/en.2007-1735","type":"journal-article","created":{"date-parts":[[2008,7,4]],"date-time":"2008-07-04T00:34:34Z","timestamp":1215131674000},"page":"5423-5431","source":"Crossref","is-referenced-by-count":122,"title":["Receptor Activity-Modifying Proteins Differentially Modulate the G Protein-Coupling Efficiency of Amylin Receptors"],"prefix":"10.1210","volume":"149","author":[{"given":"Maria","family":"Morfis","sequence":"first","affiliation":[{"name":"Drug Discovery Biology Laboratory (M.M., N.T., S.G.B.F., G.C., T.D.W., A.C., P.M.S.), Monash Institute of Pharmaceutical Sciences, and Department of Pharmacology, Monash University, Clayton, Victoria 3800, Australia"},{"name":"Howard Florey Institute and Department of Pharmacology (M.M.), The University of Melbourne, Victoria 3010, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanda","family":"Tilakaratne","sequence":"first","affiliation":[{"name":"Drug Discovery Biology Laboratory (M.M., N.T., S.G.B.F., G.C., T.D.W., A.C., P.M.S.), Monash Institute of Pharmaceutical Sciences, and Department of Pharmacology, Monash University, Clayton, Victoria 3800, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian G. B.","family":"Furness","sequence":"first","affiliation":[{"name":"Drug Discovery Biology Laboratory (M.M., N.T., S.G.B.F., G.C., T.D.W., A.C., P.M.S.), Monash Institute of Pharmaceutical Sciences, and Department of Pharmacology, Monash University, Clayton, Victoria 3800, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Christopoulos","sequence":"first","affiliation":[{"name":"Drug Discovery Biology Laboratory (M.M., N.T., S.G.B.F., G.C., T.D.W., A.C., P.M.S.), Monash Institute of Pharmaceutical Sciences, and Department of Pharmacology, Monash University, Clayton, Victoria 3800, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim D.","family":"Werry","sequence":"first","affiliation":[{"name":"Drug Discovery Biology Laboratory (M.M., N.T., S.G.B.F., G.C., T.D.W., A.C., P.M.S.), Monash Institute of Pharmaceutical Sciences, and Department of Pharmacology, Monash University, Clayton, Victoria 3800, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur","family":"Christopoulos","sequence":"first","affiliation":[{"name":"Drug Discovery Biology Laboratory (M.M., N.T., S.G.B.F., G.C., T.D.W., A.C., P.M.S.), Monash Institute of Pharmaceutical Sciences, and Department of Pharmacology, Monash University, Clayton, Victoria 3800, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick M.","family":"Sexton","sequence":"first","affiliation":[{"name":"Drug Discovery Biology Laboratory (M.M., N.T., S.G.B.F., G.C., T.D.W., A.C., P.M.S.), Monash Institute of Pharmaceutical Sciences, and Department of Pharmacology, Monash University, Clayton, Victoria 3800, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2008,7,3]]},"reference":[{"key":"2020071612244278400_R1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.pharmthera.2004.06.004","article-title":"GPCR interacting proteins (GIP).","volume":"103","author":"Bockaert","year":"2004","journal-title":"Pharmacol Ther"},{"key":"2020071612244278400_R2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev.pharmtox.46.120604.141115","article-title":"Accessory proteins for G proteins: partners in signaling.","volume":"46","author":"Sato","year":"2006","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2020071612244278400_R3","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/j.1440-1681.2005.04295.x","article-title":"G Protein-coupled receptor-protein interactions: basis for new concepts on receptor structure and function.","volume":"32","author":"Tilakaratne","year":"2005","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2020071612244278400_R4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1124\/pr.54.2.233","article-title":"International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors.","volume":"54","author":"Poyner","year":"2002","journal-title":"Pharmacol Rev"},{"key":"2020071612244278400_R5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.pharmthera.2005.06.015","article-title":"GPCR modulation by RAMPs.","volume":"109","author":"Hay","year":"2006","journal-title":"Pharmacol Ther"},{"key":"2020071612244278400_R6","author":"Young","year":"2005"},{"key":"2020071612244278400_R7","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s11892-006-0004-0","article-title":"Pramlintide: a new tool in diabetes management.","volume":"6","author":"Want","year":"2006","journal-title":"Curr Diab Rep"},{"key":"2020071612244278400_R8","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2174\/092986730611220401164504","article-title":"Calcitonin.","volume":"6","author":"Sexton","year":"1999","journal-title":"Curr Med Chem"},{"key":"2020071612244278400_R9","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1124\/mol.56.1.235","article-title":"Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product.","volume":"56","author":"Christopoulos","year":"1999","journal-title":"Mol Pharmacol"},{"key":"2020071612244278400_R10","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/30666","article-title":"RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor.","volume":"393","author":"McLatchie","year":"1998","journal-title":"Nature"},{"key":"2020071612244278400_R11","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1074\/jbc.C200629200","article-title":"Novel receptor partners and function of receptor activity-modifying proteins.","volume":"278","author":"Christopoulos","year":"2003","journal-title":"J Biol Chem"},{"key":"2020071612244278400_R12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0022-3565(24)39040-8","article-title":"Amylin receptor phenotypes derived from human calcitonin receptor\/RAMP coexpression exhibit pharmacological differences dependent on receptor isoform and host cell environment.","volume":"294","author":"Tilakaratne","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"2020071612244278400_R13","first-page":"959","article-title":"Functionally different isoforms of the human calcitonin receptor result from alternative splicing of the gene transcript.","volume":"9","author":"Moore","year":"1995","journal-title":"Mol Endocrinol"},{"key":"2020071612244278400_R14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1677\/joe.0.1670093","article-title":"Sustained activation of Erk1\/2 MAPK and cell growth suppression by the insert-negative, but not the insert-positive isoform of the human calcitonin receptor.","volume":"167","author":"Raggatt","year":"2000","journal-title":"J Endocrinol"},{"key":"2020071612244278400_R15","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1124\/mol.106.024257","article-title":"A critical role for the short intracellular C terminus in receptor activity-modifying protein function.","volume":"70","author":"Udawela","year":"2006","journal-title":"Mol Pharmacol"},{"key":"2020071612244278400_R16","first-page":"906","article-title":"Investigation and characterization of binding sites for islet amyloid polypeptide in rat membranes.","volume":"130","author":"Bhogal","year":"1992","journal-title":"Endocrinology"},{"key":"2020071612244278400_R17","doi-asserted-by":"crossref","first-page":"6720","DOI":"10.1074\/jbc.M307214200","article-title":"Spatial proximity between a photolabile residue in position 19 of salmon calcitonin and the amino terminus of the human calcitonin receptor.","volume":"279","author":"Pham","year":"2004","journal-title":"J Biol Chem"},{"key":"2020071612244278400_R18","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1124\/mol.104.008615","article-title":"Pharmacological discrimination of calcitonin receptor: receptor activity-modifying protein complexes.","volume":"67","author":"Hay","year":"2005","journal-title":"Mol Pharmacol"},{"key":"2020071612244278400_R19","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1124\/mol.106.032763","article-title":"The relaxin family peptide receptor 3 (RXFP3) activates ERK1\/2 through a PKC dependent mechanism.","volume":"71","author":"Van der Westhuizen","year":"2007","journal-title":"Mol Pharmacol"},{"key":"2020071612244278400_R20","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1111\/j.1471-4159.2005.03161.x","article-title":"Characterization of serotonin 5HT2C receptor signaling to extracellular-signal regulated kinases 1 and 2.","volume":"93","author":"Werry","year":"2005","journal-title":"J Neurochem"},{"key":"2020071612244278400_R21","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1006\/bbrc.1999.1943","article-title":"Multiple ramp domains are required for generation of amylin receptor phenotype from the calcitonin receptor gene product.","volume":"267","author":"Zumpe","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071612244278400_R22","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1210\/endo.138.8.5312","article-title":"Characterization of amylin and calcitonin receptor binding in the mouse \u03b1-TSH thyrotroph cell line.","volume":"138","author":"Perry","year":"1997","journal-title":"Endocrinology"},{"key":"2020071612244278400_R23","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1124\/mol.105.021915","article-title":"Distinct receptor activity-modifying protein domains differentially modulate interaction with calcitonin receptors.","volume":"69","author":"Udawela","year":"2006","journal-title":"Mol Pharmacol"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/149\/11\/5423\/8995360\/endo5423.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/149\/11\/5423\/8995360\/endo5423.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T23:01:19Z","timestamp":1738278079000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/149\/11\/5423\/2455119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,3]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2007-1735","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,3]]}}}